171 related articles for article (PubMed ID: 19628293)
1. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
Moody TW; Switzer C; Santana-Flores W; Ridnour LA; Berna M; Thill M; Jensen RT; Sparatore A; Del Soldato P; Yeh GC; Roberts DD; Giaccone G; Wink DA
Lung Cancer; 2010 May; 68(2):154-60. PubMed ID: 19628293
[TBL] [Abstract][Full Text] [Related]
2. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.
Sharma SD; Meeran SM; Katiyar SK
Mol Cancer Ther; 2010 Mar; 9(3):569-80. PubMed ID: 20145019
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
Dohadwala M; Yang SC; Luo J; Sharma S; Batra RK; Huang M; Lin Y; Goodglick L; Krysan K; Fishbein MC; Hong L; Lai C; Cameron RB; Gemmill RM; Drabkin HA; Dubinett SM
Cancer Res; 2006 May; 66(10):5338-45. PubMed ID: 16707460
[TBL] [Abstract][Full Text] [Related]
4. Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin.
Hou H; Yu X; Cong P; Zhou Y; Xu Y; Jiang Y
Cell Prolif; 2019 Jul; 52(4):e12617. PubMed ID: 31012173
[TBL] [Abstract][Full Text] [Related]
5. Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion.
Yu SL; Koo H; Lee HY; Yeom YI; Lee DC; Kang J
Cell Oncol (Dordr); 2019 Jun; 42(3):275-285. PubMed ID: 30697674
[TBL] [Abstract][Full Text] [Related]
6. Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells.
Cho Y; Park MJ; Park M; Min SS; Yee J; Kim C; Han MS; Han SH
Respirology; 2009 Aug; 14(6):850-8. PubMed ID: 19703066
[TBL] [Abstract][Full Text] [Related]
7. Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.
Isenberg JS; Jia Y; Field L; Ridnour LA; Sparatore A; Del Soldato P; Sowers AL; Yeh GC; Moody TW; Wink DA; Ramchandran R; Roberts DD
Br J Pharmacol; 2007 May; 151(1):63-72. PubMed ID: 17351657
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation.
Hattar K; Savai R; Subtil FS; Wilhelm J; Schmall A; Lang DS; Goldmann T; Eul B; Dahlem G; Fink L; Schermuly RT; Banat GA; Sibelius U; Grimminger F; Vollmer E; Seeger W; Grandel U
Cancer Immunol Immunother; 2013 Feb; 62(2):309-20. PubMed ID: 22923191
[TBL] [Abstract][Full Text] [Related]
9. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.
Yang P; Cartwright C; Chan D; Ding J; Felix E; Pan Y; Pang J; Rhea P; Block K; Fischer SM; Newman RA
Mol Carcinog; 2014 Jul; 53(7):566-77. PubMed ID: 23371504
[TBL] [Abstract][Full Text] [Related]
11. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
[TBL] [Abstract][Full Text] [Related]
13. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
14. Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations.
Sun SY; Schroeder CP; Yue P; Lotan D; Hong WK; Lotan R
Cancer Biol Ther; 2005 Apr; 4(4):407-13. PubMed ID: 15846100
[TBL] [Abstract][Full Text] [Related]
15. A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer.
Tang YA; Wen WL; Chang JW; Wei TT; Tan YH; Salunke S; Chen CT; Chen CS; Wang YC
PLoS One; 2010 Sep; 5(9):e12417. PubMed ID: 20856855
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI.
Weng CH; Chen LY; Lin YC; Shih JY; Lin YC; Tseng RY; Chiu AC; Yeh YH; Liu C; Lin YT; Fang JM; Chen CC
Oncogene; 2019 Jan; 38(4):455-468. PubMed ID: 30111817
[TBL] [Abstract][Full Text] [Related]
17. High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.
Li N; Xu L; Zhang J; Liu Y
Int J Exp Pathol; 2022 Jun; 103(3):90-101. PubMed ID: 35366027
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
[TBL] [Abstract][Full Text] [Related]
20. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]